We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
1951
MFA Financial
MFA
$928M
| $321K | ﹤0.01% |
19,914
| – | – |
|
1952
OptimizeRx
OPRX
$130M
| $321K | ﹤0.01% |
8,508
+1,753
| +26% | +$77.6K |
|
|
HSKA
1953
DELISTED
Heska Corp
HSKA
| $320K | ﹤0.01% |
2,317
| – | – |
|
1954
Stock Yards Bancorp
SYBT
$2.6B
| $317K | ﹤0.01% |
6,000
+769
| +15% | +$44.1K |
|
1955
Astrana Health
ASTH
$1.71B
| $311K | ﹤0.01% |
6,416
-5,521
| -46% | -$285K |
|
1956
Atara Biotherapeutics
ATRA
$80.6M
| $310K | ﹤0.01% |
+1,336
| New | +$425K |
|
1957
The Greenbrier Companies
GBX
$1.43B
| $309K | ﹤0.01% |
5,999
| – | – |
|
1958
W&T Offshore
WTI
$575M
| $307K | ﹤0.01% |
80,269
+56,489
| +238% | +$249K |
|
1959
InfuSystem Holdings
INFU
$248M
| $306K | ﹤0.01% |
31,254
-9,521
| -23% | -$122K |
|
1960
Prothena Corp
PRTA
$473M
| $306K | ﹤0.01% |
8,363
-1,554
| -16% | -$56K |
|
|
NPTN
1961
DELISTED
NEOPHOTONICS CORP
NPTN
| $306K | ﹤0.01% |
20,144
-7,727
| -28% | -$118K |
|
1962
Clearfield
CLFD
$400M
| $305K | ﹤0.01% |
4,678
-4,297
| -48% | -$270K |
|
1963
Upbound Group
UPBD
$1.11B
| $303K | ﹤0.01% |
12,031
-9,671
| -45% | -$349K |
|
1964
H.B. Fuller
FUL
$3.34B
| $302K | ﹤0.01% |
+4,575
| New | +$322K |
|
|
VIVO
1965
DELISTED
Meridian Bioscience Inc
VIVO
| $302K | ﹤0.01% |
11,622
-4,508
| -28% | -$107K |
|
1966
Etsy
ETSY
$7.29B
| $301K | ﹤0.01% |
2,425
-11,953
| -83% | -$1.78M |
|
1967
SiriusPoint
SPNT
$2.62B
| $300K | ﹤0.01% |
40,081
-22,868
| -36% | -$181K |
|
1968
Kodiak Sciences
KOD
$2.64B
| $297K | ﹤0.01% |
+38,411
| New | +$1.5M |
|
1969
Monarch Casino & Resort
MCRI
$2.19B
| $293K | ﹤0.01% |
3,362
-3,662
| -52% | -$274K |
|
|
ECHO
1970
EchoStar
ECHO
$25.6B
| $292K | ﹤0.01% |
12,147
+2,826
| +30% | +$69.6K |
|
1971
ICF International
ICFI
$1.62B
| $291K | ﹤0.01% |
+3,087
| New | +$290K |
|
|
ALLK
1972
DELISTED
Allakos
ALLK
| $287K | ﹤0.01% |
50,429
+15,850
| +46% | +$102K |
|
|
FARO
1973
DELISTED
Faro Technologies
FARO
| $287K | ﹤0.01% |
5,527
-740
| -12% | -$41.3K |
|
1974
Rapid7
RPD
$902M
| $284K | ﹤0.01% |
2,552
-3,755
| -60% | -$377K |
|
1975
Xencor
XNCR
$1.64B
| $284K | ﹤0.01% |
+10,662
| New | +$344K |
|
Similar funds
VGA
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.